Natural variability of TRAIL, IP-10, and CRP in healthy adults - The "HERACLES" study

Cytokine. 2024 Apr:176:156530. doi: 10.1016/j.cyto.2024.156530. Epub 2024 Feb 2.

Abstract

A novel host-protein score (called MMBV) helps to distinguish bacterial from viral infection by combining the blood concentrations of three biomarkers: tumour necrosis factor related apoptosis inducing ligand (TRAIL), interferon gamma induced protein 10 (IP-10), and C-reactive protein (CRP). These host biomarkers are differentially expressed in response to bacterial versus viral acute infection. We conducted a prospective study, with a time series design, in healthy adult volunteers in the Netherlands. The aim was to determine the variability of TRAIL, IP-10, and CRP and the MMBV score in healthy adults across time. Up to six blood samples were taken from each healthy volunteer over a period of up to four weeks. In 77 healthy participants without recent or current symptoms, MMBV scores (maximal) were bacterial in 1.3 % and viral (or other non-infectious etiology) in 93.5 % of participants. There was little variation in the mean concentrations of TRAIL (74.5 pg/ml), IP-10 (113.6 pg/ml), and CRP (1.90 mg/L) as well as the MMBV score. The variability of biomarker measurement was comparable to the precision of the measurement platform for TRAIL, IP-10, and CRP. Our findings establish the mean values of these biomarkers and MMBV in healthy individuals and indicate little variability between and within individuals over time, supporting the potential utility of this novel diagnostic to detect infection-induced changes.

Keywords: Biomarkers; COVID-19; CRP; IP-10; Respiratory viruses; TRAIL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers
  • C-Reactive Protein* / analysis
  • Chemokine CXCL10
  • Humans
  • Ligands
  • Prospective Studies
  • Tumor Necrosis Factor-alpha
  • Virus Diseases*

Substances

  • C-Reactive Protein
  • Chemokine CXCL10
  • Ligands
  • Biomarkers
  • Tumor Necrosis Factor-alpha